Epilepsy is a syndrome of episodic brain dysfunction characterized by recurrent seemingly unpredictable spontaneous seizures. The occurrence of the seizure in patients without any forewarning is the most debilitating aspect of the disease. The Epicall system is intended for early detection of seizure related life threatening events by monitoring per-seizures biomarkers. The system is based on a sticker placed on the side of the face. The external sticker incorporates EOG (electrooculograph electrode) and PPG (photoplethysmograph electrode) sensors for continuous monitoring of: 1. Heart Rate (base line, increase, decrease, asystole). 2. Extra ocular eye movement (blinking, eye deviation, roving eye movements).
Study Type
OBSERVATIONAL
Enrollment
30
The Epicall system is intended for early detection of seizure by monitoring pre-seizure biomarkers.
Asaf Harofeh Medical Center
Zrifin, Israel
Lack of adverse events
Time frame: 1-2 weeks
Epicall feasibility for monitoring pre-seizure biomarkers
Feasibility of using the Epicall for monitoring pre-seizure biomarkers will be established by the correlation between Epicall and ECG heart rate measurements.
Time frame: 1-2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.